RxSight, Inc. (NASDAQ: RXST)

This lawsuit is for anyone who acquired securities in RxSight, Inc. (NASDAQ: RXST) from May 7, 2024 through July 8, 2025.

The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled investors by failing to timely disclose to investors that customers were having trouble adjusting to and adopting the Company’s products.

On July 9, 2025, RxSight reported preliminary second quarter 2025 financial results, revealing significant declines in Light Delivery Devices (“LDD”) sales, light adjustable intraocular lenses (“LAL”) utilization, and overall revenue. The Company also lowered its Full Year 2025 guidance by approximately $42.5 million at the midpoint and stated that “[a]doption challenges over the last few quarters have been a primary reason for the LDD stall.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in RxSight, Inc. (NASDAQ: RXST) from May 7, 2024 through July 8, 2025 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.